2021 AHA_ASA指南:卒中和短暂性脑缺血发作患者的卒中预防

2021-05-24 美国心脏协会 Stroke.2021 May 24;

2021年5月,美国心脏协会(AHA)联合美国卒中协会(ASA)共同发布了卒中和短暂性脑缺血发作患者的卒中预防指南。本文主要针对缺血性卒中和短暂性脑缺血发作生存者未来卒中的预防提供循证指导建议,内容涉

中文标题:

2021 AHA_ASA指南:卒中和短暂性脑缺血发作患者的卒中预防

英文标题:

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association

发布机构:

美国心脏协会

发布日期:

2021-05-24

简要介绍:

2021年5月,美国心脏协会(AHA)联合美国卒中协会(ASA)共同发布了卒中和短暂性脑缺血发作患者的卒中预防指南。本文主要针对缺血性卒中和短暂性脑缺血发作生存者未来卒中的预防提供循证指导建议,内容涉及继发性卒中预防的诊断评估,血管危险因素的管理,病因学管理以及继发性卒中的系统护理。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 AHA_ASA指南:卒中和短暂性脑缺血发作患者的卒中预防.pdf)] GetToolGuiderByIdResponse(projectId=1, id=001eb1c002112584, title=2021 AHA_ASA指南:卒中和短暂性脑缺血发作患者的卒中预防, enTitle=2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association, guiderFrom=Stroke.2021 May 24;, authorId=0, author=, summary=2021年5月,美国心脏协会(AHA)联合美国卒中协会(ASA)共同发布了卒中和短暂性脑缺血发作患者的卒中预防指南。本文主要针对缺血性卒中和短暂性脑缺血发作生存者未来卒中的预防提供循证指导建议,内容涉, cover=https://img.medsci.cn/2021618/1623983080095_2020535.png, journalId=0, articlesId=null, associationId=60, associationName=美国心脏协会, associationIntro=美国心脏协会(AHA,American Heart Association)是心脏病学领域比较正要的学会之一,致力于心脏病和卒中的预防与治疗,提供相关继续教育、流行病学年度报告。每年举办学术年会报道中的的临床试验结果等,有官方杂志《美国心脏协会杂志》,提供心血管疾病和卒中相关的指南及专家共识,更新的比较快。, copyright=0, guiderPublishedTime=Mon May 24 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年5月,美国心脏协会(AHA)联合美国卒中协会(ASA)共同发布了卒中和短暂性脑缺血发作患者的卒中预防指南。本文主要针对缺血性卒中和短暂性脑缺血发作生存者未来卒中的预防提供循证指导建议,内容涉及继发性卒中预防的诊断评估,血管危险因素的管理,病因学管理以及继发性卒中的系统护理。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=3482, tagName=短暂性脑缺血发作)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=3482, guiderKeyword=短暂性脑缺血发作, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9616, appHits=569, showAppHits=0, pcHits=1361, showPcHits=9046, likes=5, shares=32, comments=24, approvalStatus=1, publishedTime=Fri Jun 18 13:15:45 CST 2021, publishedTimeString=2021-05-24, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Fri Jun 18 10:24:57 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 22:05:13 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 AHA_ASA指南:卒中和短暂性脑缺血发作患者的卒中预防.pdf)])
2021 AHA_ASA指南:卒中和短暂性脑缺血发作患者的卒中预防.pdf
下载请点击:
评论区 (22)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1242041, encodeId=65de1242041a5, content=全英文,解读呢?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bfa8299376, createdName=ms9000000803030878, createdTime=Tue Aug 30 13:14:39 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184172, encodeId=5dbb11841e204, content=学习了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b675520375, createdName=静心思, createdTime=Fri Jan 14 10:28:21 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182609, encodeId=7d6d1182609b4, content=全英文,看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be806456543, createdName=ms6000001035330278, createdTime=Sun Jan 09 20:24:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182047, encodeId=f5fb118204e21, content=学习啦,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Sat Jan 08 01:24:05 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076354, encodeId=13bc10e635484, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8ca105034, createdName=zhaopeng8933, createdTime=Thu Dec 02 22:23:31 CST 2021, time=2021-12-02, status=1, ipAttribution=)]
    2022-08-30 ms9000000803030878

    全英文,解读呢?

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1242041, encodeId=65de1242041a5, content=全英文,解读呢?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bfa8299376, createdName=ms9000000803030878, createdTime=Tue Aug 30 13:14:39 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184172, encodeId=5dbb11841e204, content=学习了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b675520375, createdName=静心思, createdTime=Fri Jan 14 10:28:21 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182609, encodeId=7d6d1182609b4, content=全英文,看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be806456543, createdName=ms6000001035330278, createdTime=Sun Jan 09 20:24:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182047, encodeId=f5fb118204e21, content=学习啦,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Sat Jan 08 01:24:05 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076354, encodeId=13bc10e635484, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8ca105034, createdName=zhaopeng8933, createdTime=Thu Dec 02 22:23:31 CST 2021, time=2021-12-02, status=1, ipAttribution=)]
    2022-01-14 静心思

    学习了,谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1242041, encodeId=65de1242041a5, content=全英文,解读呢?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bfa8299376, createdName=ms9000000803030878, createdTime=Tue Aug 30 13:14:39 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184172, encodeId=5dbb11841e204, content=学习了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b675520375, createdName=静心思, createdTime=Fri Jan 14 10:28:21 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182609, encodeId=7d6d1182609b4, content=全英文,看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be806456543, createdName=ms6000001035330278, createdTime=Sun Jan 09 20:24:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182047, encodeId=f5fb118204e21, content=学习啦,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Sat Jan 08 01:24:05 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076354, encodeId=13bc10e635484, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8ca105034, createdName=zhaopeng8933, createdTime=Thu Dec 02 22:23:31 CST 2021, time=2021-12-02, status=1, ipAttribution=)]
    2022-01-09 ms6000001035330278

    全英文,看不懂

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1242041, encodeId=65de1242041a5, content=全英文,解读呢?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bfa8299376, createdName=ms9000000803030878, createdTime=Tue Aug 30 13:14:39 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184172, encodeId=5dbb11841e204, content=学习了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b675520375, createdName=静心思, createdTime=Fri Jan 14 10:28:21 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182609, encodeId=7d6d1182609b4, content=全英文,看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be806456543, createdName=ms6000001035330278, createdTime=Sun Jan 09 20:24:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182047, encodeId=f5fb118204e21, content=学习啦,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Sat Jan 08 01:24:05 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076354, encodeId=13bc10e635484, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8ca105034, createdName=zhaopeng8933, createdTime=Thu Dec 02 22:23:31 CST 2021, time=2021-12-02, status=1, ipAttribution=)]
    2022-01-08 杨小屁

    学习啦,

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1242041, encodeId=65de1242041a5, content=全英文,解读呢?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bfa8299376, createdName=ms9000000803030878, createdTime=Tue Aug 30 13:14:39 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184172, encodeId=5dbb11841e204, content=学习了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b675520375, createdName=静心思, createdTime=Fri Jan 14 10:28:21 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182609, encodeId=7d6d1182609b4, content=全英文,看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be806456543, createdName=ms6000001035330278, createdTime=Sun Jan 09 20:24:58 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182047, encodeId=f5fb118204e21, content=学习啦,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Sat Jan 08 01:24:05 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076354, encodeId=13bc10e635484, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8ca105034, createdName=zhaopeng8933, createdTime=Thu Dec 02 22:23:31 CST 2021, time=2021-12-02, status=1, ipAttribution=)]
    2021-12-02 zhaopeng8933

    受益匪浅

    0

拓展阅读

2016 中国短暂性脑缺血发作早期诊治指导规范(2016年)

国家卫生计生委脑卒中防治工程委员会 · 2016-05-08

2021 ESO指南:短暂性脑缺血发作的管理

欧洲卒中组织(ESO,European Stroke Organisation) · 2021-06-02

2022更新—2019 NICE指南:大于16岁人群卒中和短暂性脑缺血发作的诊断和初期管理(NG.128)

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2022-04-13

2022 ESO 指南:缺血性卒中或短暂性脑缺血发作后长期二级预防药物干预

欧洲卒中组织(ESO,European Stroke Organisation) · 2022-06-03